Literature DB >> 9634799

N-glycosylation of recombinant human interferon-gamma produced in different animal expression systems.

D C James1, R B Freedman, M Hoare, O W Ogonah, B C Rooney, O A Larionov, V N Dobrovolsky, O V Lagutin, N Jenkins.   

Abstract

Recombinant human interferon-gamma (IFN-gamma) was expressed in Chinese hamster ovary cells, baculovirus-infected Sf9 insect cells and the mammary gland of transgenic mice. The N-linked carbohydrate populations associated with both Asn25 and Asn97 glycosylation sites were characterized by matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS) in combination with exoglycosidase array sequencing. A site-specific analysis of dual (2N) and single (1N) site-occupancy variants of IFN-gamma derived from Chinese hamster ovary cells showed that N-glycans were predominantly of the complex bi- and triantennary type. Although Asn25-linked glycans were substituted with a core fucose residue, Asn97 N-glycans were predominantly non-fucosylated, and truncated complex and high-mannose oligosaccharide chains were also evident. Transgenic mouse derived IFN-gamma exhibited considerable site-specific variation in N-glycan structures. Asn25-linked carbohydrates were of the complex, core fucosylated type, Asn97-linked carbohydrates were mainly of the oligomannose type, with smaller proportions of hybrid and complex N-glycans. Carbohydrates associated with both glycosylation sites of IFN-gamma from Sf9 insect cells were mainly tri-mannosyl core structures, with fucosylation confined to the Asn25 site. These data demonstrate the profound influence of host cell type and protein structure on the N-glycosylation of recombinant proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9634799     DOI: 10.1038/nbt0695-592

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  21 in total

Review 1.  The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins.

Authors:  A J Clark
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  Analysis of glycoprotein heterogeneity by capillary electrophoresis and mass spectrometry.

Authors:  A D Hooker; D C James
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

3.  Analysis of recombinat glycoproteins by mass spectrometry.

Authors:  D C James
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

4.  Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ.

Authors:  L Monaco; A Marc; A Eon-Duval; G Acerbis; G Distefano; D Lamotte; J M Engasser; M Soria; N Jenkins
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 5.  In vivo protein crystallization in combination with highly brilliant radiation sources offers novel opportunities for the structural analysis of post-translationally modified eukaryotic proteins.

Authors:  Michael Duszenko; Lars Redecke; Celestin Nzanzu Mudogo; Benjamin Philip Sommer; Stefan Mogk; Dominik Oberthuer; Christian Betzel
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-07-29       Impact factor: 1.056

6.  Tetramerization domain of human butyrylcholinesterase is at the C-terminus.

Authors:  R M Blong; E Bedows; O Lockridge
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

7.  Purification and N-glycosylation analysis of melanoma antigen dopachrome tautomerase.

Authors:  Christopher J Vavricka; Keith W Ray; Bruce M Christensen; Jianyong Li
Journal:  Protein J       Date:  2010-04       Impact factor: 2.371

Review 8.  Insect cells as hosts for the expression of recombinant glycoproteins.

Authors:  F Altmann; E Staudacher; I B Wilson; L März
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

Review 9.  Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells.

Authors:  E Grabenhorst; P Schlenke; S Pohl; M Nimtz; H S Conradt
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

10.  Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Glycobiology       Date:  2008-05-02       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.